share_log

艾美疫苗：截至二零二四年九月三十日止之股份發行人的證券變動月報表

AIM VACCINE: Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2024

HKEX ·  Oct 4 16:37

Summary by Futu AI

艾美疫苗股份有限公司於2024年9月30日提交了最新的證券變動月報表。報告顯示，公司的H股法定/註冊股份數目維持在492,173,711股，每股面值1人民幣，並無增減變動。同時，內資股法定/註冊股份數目亦保持在718,888,888股，每股面值1人民幣，本月亦無變動。總結算，艾美疫苗的法定/註冊股本總額為1,211,062,599人民幣。此外，公司已發行股份（不包括庫存股份）數目與上月相同，H股為492,173,711股，內資股為718,888,888股。報告中亦提及，公司於2020年11月30日採納並於2022年2月16日修訂的首次公開發售前僱員股份激勵計劃，本月底結存的股份期權數目為3,141,000。艾美疫苗確認，所有證券發行或庫存股份的出售或轉讓均已獲得董事會授權，並遵守相關上市規則及法律規定。報告由聯席公司秘書劉靈於2024年10月4日呈交。
艾美疫苗股份有限公司於2024年9月30日提交了最新的證券變動月報表。報告顯示，公司的H股法定/註冊股份數目維持在492,173,711股，每股面值1人民幣，並無增減變動。同時，內資股法定/註冊股份數目亦保持在718,888,888股，每股面值1人民幣，本月亦無變動。總結算，艾美疫苗的法定/註冊股本總額為1,211,062,599人民幣。此外，公司已發行股份（不包括庫存股份）數目與上月相同，H股為492,173,711股，內資股為718,888,888股。報告中亦提及，公司於2020年11月30日採納並於2022年2月16日修訂的首次公開發售前僱員股份激勵計劃，本月底結存的股份期權數目為3,141,000。艾美疫苗確認，所有證券發行或庫存股份的出售或轉讓均已獲得董事會授權，並遵守相關上市規則及法律規定。報告由聯席公司秘書劉靈於2024年10月4日呈交。
EMI Vaccine Co., Ltd. submitted its latest monthly report on securities changes on September 30, 2024. The report shows that the company's H shares legal/registered share capital remained at 492,173,711 shares, with a par value of 1 RMB per share, without any increase or decrease. At the same time, the legal/registered share capital of domestic shares also remained at 718,888,888 shares, with a par value of 1 RMB per share, with no changes this month. In summary, EMI Vaccine's total legal/registered share capital amounts to 1,211,062,599 RMB. Furthermore, the number of issued shares (excluding treasury shares) remains the same as last month, with H shares at 492,173,711 shares and domestic shares at 718,888,888 shares. The report also mentions that the company adopted its first...Show More
EMI Vaccine Co., Ltd. submitted its latest monthly report on securities changes on September 30, 2024. The report shows that the company's H shares legal/registered share capital remained at 492,173,711 shares, with a par value of 1 RMB per share, without any increase or decrease. At the same time, the legal/registered share capital of domestic shares also remained at 718,888,888 shares, with a par value of 1 RMB per share, with no changes this month. In summary, EMI Vaccine's total legal/registered share capital amounts to 1,211,062,599 RMB. Furthermore, the number of issued shares (excluding treasury shares) remains the same as last month, with H shares at 492,173,711 shares and domestic shares at 718,888,888 shares. The report also mentions that the company adopted its first employee stock incentive plan before the initial public offering on November 30, 2020, as revised on February 16, 2022. The number of stock options outstanding at the end of this month is 3,141,000. EMI Vaccine confirms that all securities issuances or sales of treasury shares have been authorized by the board of directors and comply with relevant listing rules and legal requirements. The report was submitted by joint company secretary Liu Ling on October 4, 2024.

This announcement is a separate document:

Doc 1     View Translation

The translation is provided by third-party software.


The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Heat List
    US
    SymbolLatest Price% Chg

    No Data

    Hot News
    Updated